
This episode discusses the advancements in hemophilia treatment and the importance of shared decision making for better health outcomes.
We explore how new non‑factor options and high‑sustained factor products are changing hemophilia care and why shared decision making leads to better, more flexible lives. We connect treatment choice to joint health, mental health, aging, and everyday habits that protect long‑term outcomes. • Non‑factor prophylaxis versus factor replacement and what each does best • Treating beyond dated trough targets toward durable thrombin generation • Matching therapy to activity level, joint status, and ...
Organizations: Creative Educational Concepts
Products: non‑factor options, high‑sustained factor products, non‑factor prophylaxis, factor replacement, durable thrombin generation
Explore listener stats, chart rankings, contacts and more on the CEConversations podcast page.